Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor–Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00Marco Colleoni, Aron Goldhirsch, Shari Gelber et al.|Journal of Clinical Oncology|2016Cited by 77